Loading clinical trials...
Loading clinical trials...
A Phase I/II Trial of Venetoclax and BEAM Conditioning Followed by Autologous Stem Cell Transplantation for Patients With Primary Refractory Non-Hodgkin Lymphoma
Conditions
Interventions
Carmustine
Cytarabine
+4 more
Locations
1
United States
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Start Date
September 10, 2018
Primary Completion Date
September 30, 2021
Completion Date
September 30, 2021
Last Updated
May 14, 2025
NCT05272384
NCT07042438
NCT05755087
NCT07098364
NCT05672251
NCT06905509
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions